| Johnson & Johnson said it submitted an application seeking emergency use authorization for its investigational single-dose Covid-19 vaccine candidate to the U.S. Food and Drug Administration. The company also said it is ready to begin shipping the product upon authorization for emergency use, adding it “expects to supply 100 million doses to the U.S. in the first half of 2021.” | 
